{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:05:06Z","timestamp":1791421506459,"version":"4.3.3"},"reference-count":52,"publisher":"American Chemical Society (ACS)","issue":"5","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2243"],"award-info":[{"award-number":["GRK2243"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54 GM115458"],"award-info":[{"award-number":["U54 GM115458"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2025,3,13]]},"DOI":"10.1021\/acs.jmedchem.4c02464","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T19:12:18Z","timestamp":1740769938000},"page":"5400-5425","source":"Crossref","is-referenced-by-count":3,"title":["Structural Optimization of Covalent Inhibitors for Deubiquitinase ChlaDUB1 of <i>Chlamydia trachomatis<\/i> as Antibiotic Agents"],"prefix":"10.1021","volume":"68","author":[{"given":"Thomas","family":"Zimmermann","sequence":"first","affiliation":[{"name":"Pharmazeutische und Medizinische Chemie, Institut f\u00fcr Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universit\u00e4t W\u00fcrzburg (JMU), Am Hubland, 97074 W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy","place":["Omaha, United States"]},{"name":"University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8934-6443","authenticated-orcid":true,"given":"Simon","family":"Fischer","sequence":"additional","affiliation":[{"name":"Pharmazeutische und Medizinische Chemie, Institut f\u00fcr Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universit\u00e4t W\u00fcrzburg (JMU), Am Hubland, 97074 W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana Jana\u00edna","family":"de Campos","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy","place":["Omaha, United States"]},{"name":"University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Ramos","family":"Pinheiro","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy","place":["Omaha, United States"]},{"name":"University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-4068","authenticated-orcid":true,"given":"Christoph","family":"Sotriffer","sequence":"additional","affiliation":[{"name":"Pharmazeutische und Medizinische Chemie, Institut f\u00fcr Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universit\u00e4t W\u00fcrzburg (JMU), Am Hubland, 97074 W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3568-2545","authenticated-orcid":true,"given":"Martin","family":"Conda-Sheridan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy","place":["Omaha, United States"]},{"name":"University of Nebraska Medical Center","place":["Omaha, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6773-6245","authenticated-orcid":true,"given":"Michael","family":"Decker","sequence":"additional","affiliation":[{"name":"Pharmazeutische und Medizinische Chemie, Institut f\u00fcr Pharmazie und Lebensmittelchemie, Julius-Maximilians-Universit\u00e4t W\u00fcrzburg (JMU), Am Hubland, 97074 W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143304"},{"key":"ref2\/cit2","unstructured":"WHO. Chlamydia, 2023, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chlamydia.\n(accessed June 03, 2024)."},{"key":"ref3\/cit3","unstructured":"CDC. Sexually Transmitted\nInfections Surveillance, 2022, 2024, https:\/\/www.cdc.gov\/std\/statistics\/2022\/default.htm. (accessed June 03, 2024)."},{"key":"ref4\/cit4","unstructured":"WHO. WHO guidelines\nfor the treatment of Chlamydia trachomatis, 2016, https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/246165\/9789241549714-eng.pdf."},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh283"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02097-13"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.9.2268"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1128\/aac.49.5.1787-1793.2005"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a010256"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2009.01364.x"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003102"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-00995-0"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.21465"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00922-9"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00230"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.4c00267"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13136"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.87386"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.06.015"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0271-y"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1042\/bj2900205"},{"key":"ref22\/cit22","unstructured":"Ramirez, Y. A. Structural basis of ubiquitin recognition and rational design of novel covalent inhibitors targeting Cdu1 from Chlamydia Trachomatis. Ph.D. Dissertation. Julius Maximilian University Wuerzburg, 2019."},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202306119"},{"key":"ref24\/cit24","unstructured":"Yamazaki, T.; Kikumoto, S.; Ono, M.; Saitou, A.; Takahashi, H.; Kumakura, S.; Hirose, K.; Yanaka, M.; Takemura, Y.; Suzuki, S.; Matsui, R. Amine Compounds and use thereof. US2007\/0208033A12007."},{"key":"ref25\/cit25","unstructured":"Kemp, M.; Stockley, M.; Jones, A. Cyanopyrrolidines as DUB inhibitors for the treatment of cancer. WO2017\/009650A1, 2017."},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.8b00507"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201800364"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33559-4"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M802074200"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1021\/jm00341a003"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00129-0"},{"key":"ref32\/cit32","unstructured":"molinspiration - Calculation of Molecular Physiochemical\nProperties. https:\/\/www.molinspiration.com\/services\/properties.html (accessed\nMarch 22, 2024)."},{"key":"ref33\/cit33","doi-asserted-by":"crossref","DOI":"10.1002\/9781118540398","volume-title":"Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists","author":"Copeland R. A.","year":"2013"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612973"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2018.06.009"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.plaphy.2017.01.009"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01138"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00172"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01894"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01802-14"},{"key":"ref41\/cit41","volume-title":"2019.01; Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7","author":"Molecular Operating Environment (MOE)","year":"2022"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1996.0897"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007996124545"},{"key":"ref44\/cit44","unstructured":"CCDC; GOLD User Guide.\n2022.3 CSD Release. https:\/\/www.ccdc.cam.ac.uk\/media\/Documentation\/0C5D99BC-7CC3-49B6-8319-06BEA8CA342D\/GOLD_User_Guide_2020_1.pdf. (accessed 15.01.2024)."},{"key":"ref45\/cit45","unstructured":"The Pymol Molecular\nGraphics System, Version 2.4.1, Schr\u00f6dinger,\nLLC."},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1177\/1087057109336751"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00371"},{"key":"ref48\/cit48","volume-title":"CLSI Document M07-A9. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically: Approved Standard","author":"CLSI; Wayne","year":"2012","edition":"19"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1021\/jm301661h"},{"issue":"4","key":"ref50\/cit50","first-page":"441","volume":"7","author":"Nilsson J. L.","year":"1970","journal-title":"Acta Pharm. Suec."},{"key":"ref51\/cit51","unstructured":"Jae Uk, C.; Kyung-yun, J.; Min-Wook, J.; Hee-Kyung, J.; Hyun-Ju, L. Novel Compounds of Reverse Turn Mimetics and the Use Thereof. US2010\/0286094A1, 2008."},{"key":"ref52\/cit52","unstructured":"Amin, K.; Broddefalk, J.; Desfosses, H.; Evertsson, E.; Liu, Z.; Milburn, C.; Nilsson, K.; Tremblay, M.; Walpole, C.; Wei, Z.; Yang, H. Therapeutic Compounds: Pyridine as Scaffold. WO2005\/115986A1, 2005."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.4c02464","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.4c02464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:32:20Z","timestamp":1741854740000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.4c02464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,3,13]]}},"alternative-id":["10.1021\/acs.jmedchem.4c02464"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02464","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}